9.6.2022 12:41:51 CEST | Aqua Bio Technology ASA | Major shareholding
notifications

Edvard Cock has, as chairman of the Board of Directors of Aqua Bio Technology
ASA ("ABT"), received proxies to vote for 4,801,230 shares at the annual general
meeting on 9 June 2022 (the "AGM") without any voting instructions, representing
approx. 23,2% of the total shares and votes in the company. Håvard Lindstrøm, as
CEO, received proxies to vote for 1,357,566 shares, without any voting
instructions, representing 6,58% of the shares and votes in the company. The
proxies received are only valid for the AGM and will lapse automatically
thereafter.

Further, Blixen Invest AS, a company wholly-owned by Edvard Cock, holds
1,280,793 shares in ABT, and together with the received proxies, Edvard Cock may
therefore vote for 6,082,023 shares, representing approx. 29,49% of the votes in
the company.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941
32 288.

* * *

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward. ABT is listed on the
Euronext Expand market of the Oslo Stock Exchange. This information is subject
to the disclosure requirements pursuant to section 5-12 of the Norwegian
Securities Trading Act.

 

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Håvard Lindstrøm, 004794132288, hl@aquabiotech.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/1520/2081/Download%20announcement
%20as%20PDF.pdf